Sudarshan Chemical Industries Board Approves Q3 FY2026 Unaudited Results and Corporate Guarantee Renewal

Sudarshan Chemical Industries announced the approval of its Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. The Board also renewed a Corporate Guarantee of up to EURO 6 Million in favor of its subsidiary, Sudarshan Europe B.V., to secure working capital facilities. The trading window for company securities will reopen on February 15, 2026.

Unaudited Financial Results for Q3 FY2026

The Board of Directors of Sudarshan Chemical Industries Limited met on Thursday, February 12, 2026, and transacted key businesses, primarily focusing on financial disclosures and corporate actions. The Board approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2025, along with the Limited Review Report from the Statutory Auditors.

Standalone Performance Highlights (Q3 FY2026 vs Q3 FY2025)

The standalone performance showed mixed results compared to the previous year’s corresponding quarter:

  • Revenue from Operations stood at ₹550.3 Crore for the quarter ended December 31, 2025, down from ₹574.8 Crore in Q3 FY2025.
  • Profit Before Tax (PBT) was ₹20.0 Crore, compared to ₹23.0 Crore in Q3 FY2025.
  • Earnings Per Share (after exceptional items) was ₹2.9, against ₹2.3 in Q3 FY2025.

Consolidated Performance Highlights (Q3 FY2026 vs Q3 FY2025)

The consolidated results reflect significant impact from the recent acquisition and associated exceptional items:

  • Total Income reached ₹2,117.2 Crore for Q3 FY2026, compared to ₹670.9 Crore in Q3 FY2025.
  • The Group registered a significant (Loss) Before Tax of (₹122.8 Crore) for the quarter, heavily impacted by Exceptional Items Expense of (₹45.4 Crore).
  • Total Comprehensive Income for the quarter was a loss of (₹134.2 Crore).

Renewal of Corporate Guarantee

The Board approved the renewal of a Corporate Guarantee provided to The Hongkong and Shanghai Banking Corporation Limited on behalf of its Wholly Owned Subsidiary, Sudarshan Europe B.V. The guarantee amount is not to exceed EURO 6 Million. This renewal is intended to secure the Revolving Credit Facility (Working Capital) for Sudarshan Europe B.V. The management confirmed that the Promoter/Promoter Group has no interest in this transaction, and it will be disclosed as a contingent liability in the standalone financial statements.

Key Accounting and Operational Notes

The results reflect several significant events:

  • Exceptional Items: Standalone results include an impact of ₹26.5 Crore categorized as ‘Statutory impact of new Labour Codes’ due to changes in wage definition for gratuity calculations.
  • Acquisition Impact: Consolidated results for the period include the full impact of the acquisition of the global pigment business operations of the Heubach Group, completed on March 3, 2025. A Bargain Purchase Gain of ₹1,243.9 Crore was recognized in Other Comprehensive Income based on the provisional Purchase Price Allocation (PPA) under Ind AS 103.
  • Segmental Overview: The Pigments segment remains the core business, driving the majority of revenue (₹2,052.2 Crore for Q3 FY2026).

Trading Window Closure Update

The trading window for dealing in the Company’s securities will remain closed and is scheduled to open on Sunday, February 15, 2026, forty-eight hours after the declaration of these Unaudited Financial Results.

Source: BSE

Previous Article

Tega Industries Limited Monitoring Agency Report for Preferential Issue Proceeds Utilization (Q3 FY2026)

Next Article

Entero Healthcare Solutions Limited Q3 & 9M FY26 Investor Presentation Highlights Strong Growth and Strategic Acquisitions